India to Uganda: Actinomycin Export Trade Route
India has recorded 22 verified shipments of Actinomycin exported to Uganda, representing a combined trade value of $37.6K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $1.7K USD. The leading Indian exporter is ZUVIUS LIFESCIENCES PRIVATE LIMITED, which accounts for 88% of total export value with 3 shipments worth $33.2K USD. On the buying side, ONCOPHARM SPECIALITY PHARMACY is the largest importer in Uganda with $33.2K USD in purchases. The top 3 suppliers — ZUVIUS LIFESCIENCES PRIVATE LIMITED, RMPL PHARMA LLP , RMPL PHARMA LLP — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Uganda Actinomycin corridor is one of India's established pharmaceutical export routes, with 22 shipments documented worth a combined $37.6K USD. The route is dominated by ZUVIUS LIFESCIENCES PRIVATE LIMITED, which alone accounts for roughly 88% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $1.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 18.3%, placing it at rank #15 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Uganda include ONCOPHARM SPECIALITY PHARMACY, TO THE ORDER OF INVOICE RAISED TO , INVOICE RAISED TO and 2 others. ONCOPHARM SPECIALITY PHARMACY is the single largest importer with 3 shipments valued at $33.2K USD.
